See the markers behind recurrent skin infections
Track HbA1c, hs-CRP, and white blood cell count with one blood panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What is cellulitis?
Cellulitis is an acute, spreading bacterial skin infection that reaches past the surface into the dermis and the fatty subcutaneous tissue beneath it. As a soft tissue infection, cellulitis causes erythema (redness or a change in skin color), warmth, swelling, and tenderness across the affected area, usually on one limb.
What separates cellulitis from an ordinary spot or bite is the shape of the redness. Cellulitis typically shows up as a poorly demarcated, expanding patch with swelling and pain rather than a neat circle you can trace, and moderate to severe cases arrive with systemic signs: fever, malaise, and swollen lymph nodes near the site.
This is a common infection, not a rare one. Cellulitis occurs at a rate of about 24.6 cases per 1,000 person-years, and roughly three-quarters of people who develop it are managed as outpatients rather than admitted to hospital.
How cellulitis differs from erysipelas, abscess, and other look-alikes
A red, warm leg is not automatically cellulitis. Close to one-third of presumed cellulitis turns out to be a non-infectious mimic, a pattern clinicians call pseudocellulitis, which is why the shape and distribution of the redness matter as much as its presence. The single most useful rule of thumb: cellulitis is almost always confined to one limb rather than both, so redness flaring in both legs at once points somewhere else.
| Condition | Depth of infection or process | Border definition | One side or both | Typical onset | Usual management |
|---|---|---|---|---|---|
| Cellulitis | Dermis and subcutaneous fat | Poorly defined, spreading edge | Almost always one limb | Hours to days | Antibiotics, oral or intravenous by severity |
| Erysipelas | More superficial layers of skin | Sharply demarcated, raised edge | Usually one area | Rapid, often with fever | Antibiotics aimed at streptococci |
| Skin abscess | Walled-off pocket of pus | Well defined, often a tender lump | One site | Days | Drainage, with antibiotics as needed |
| Deep vein thrombosis (DVT) | Clot in a deep leg vein, not an infection | Diffuse swelling, little true redness | One leg | Hours to days | Urgent assessment and anticoagulation |
| Stasis dermatitis | Chronic skin change from poor vein drainage | Diffuse, often scaly and pigmented | Typically both legs | Weeks to months | Compression and skin care, not antibiotics |
What does cellulitis look like? Early signs and how it progresses
Cellulitis usually begins as a small area of redness, warmth, and tenderness around a break in the skin, then spreads outward over hours to days. The giveaway is movement: the edge of the redness advances instead of holding still.
Most cases follow a recognizable arc, and knowing which point you are at is more useful than knowing the label. The local and systemic features of cellulitis tend to appear in this order:
- Early. A localized patch of redness, warmth, tenderness, and mild swelling around an entry point such as a cut, crack, or bite.
- Established. A larger warm, swollen, painful area with a spreading edge, sometimes with skin dimpling that resembles orange peel, or small blisters.
- Spreading or systemic. Rapidly enlarging redness with fever, chills, or malaise, sometimes with red streaks running toward the nearest lymph nodes as the infection tracks through the lymphatic channels.
One thing catches almost everyone out. Symptoms can look worse during the first 48 hours of antibiotics before they start to settle, so a slightly angrier-looking leg on day two is not automatically a sign that treatment has failed.
How cellulitis appears on darker skin tones
On brown and black skin, the redness of cellulitis may be much less obvious, and that visibility gap is a real clinical problem rather than a footnote: infections get missed or picked up late.
When color change is difficult to appreciate in more deeply pigmented skin, the other cardinal signs carry the weight. Pain, warmth, swelling, and firmness are the ones to trust, and the most practical check is comparison: press the same spot on the opposite side of the body and notice whether the two feel different.
What causes cellulitis and who is most at risk
Cellulitis starts when bacteria get past the skin barrier, most often Streptococcus pyogenes or Staphylococcus aureus entering through a cut, scrape, insect bite, ulcer, or surgical wound. Sometimes no entry point is ever found, which is unsatisfying but common.
Which organism is involved matters, because it steers treatment. Beta-hemolytic streptococci were confirmed as the cause in 72% of hospitalized cellulitis cases in one prospective series, and no single bedside feature reliably flags a streptococcal cause. Cellulitis accompanied by pus or an abscess is a different animal: it is more likely to involve Staphylococcus aureus, including MRSA, which is why antibiotic choice differs between purulent and non-purulent infection.
Risk is not evenly distributed, and the strongest factors are all about the skin barrier. Ordered by strength of association in pooled data:
- A previous episode of cellulitis (the single strongest factor, odds ratio 40.3)
- An open wound (odds ratio 19.1)
- A current leg ulcer (odds ratio 13.7)
- Long-standing leg swelling or lymphedema, meaning fluid build-up from a blocked lymph system (odds ratio 6.8)
- Skin conditions that provoke scratching and break the surface (odds ratio 4.4)
- Athlete's foot, or tinea pedis, which cracks the skin between the toes (odds ratio 3.2)
- A body mass index above 30 (odds ratio 2.4)
Two background factors sit further upstream and are worth understanding. Obesity is associated with roughly 2.7 times the odds of cellulitis, while being merely overweight shows no clear association. Among people with diabetes, every 1% rise in HbA1c is associated with about 12% higher odds of cellulitis, with risk about 1.4 times higher above an HbA1c of 7.5%. These are associations rather than proven causes, but both point at things that can shift over time.
Where cellulitis shows up: leg, face, arm, and periorbital cellulitis
Cellulitis can appear anywhere there is skin, though the lower leg dominates, accounting for about 40% of all cases. Lower-extremity cellulitis occurs at roughly 199 cases per 100,000 person-years, and incidence climbs about 44% with each additional decade of age, affecting men and women almost equally.
| Site | Typical trigger or entry point | Distinguishing feature | Urgency |
|---|---|---|---|
| Lower leg | Athlete's foot, leg ulcers, cracked or dry skin | Most common site; swelling and vein changes often already present | Same-week assessment; sooner if fever or spreading |
| Face | Skin breaks, dental or sinus infection | Swelling near the eye or nose raises the stakes quickly | Prompt assessment |
| Hand and arm | Trauma, animal or human bites, surgical wounds | Tendon-rich anatomy means hand infections spread along tissue planes | Prompt assessment |
| Periorbital or orbital | Sinus infection, local skin injury | Periorbital (pre-septal) sits in front of the eye socket septum; orbital (post-septal) sits behind it, with painful or restricted eye movement | Urgent specialist assessment |
The infections around the eye deserve their own attention: orbital complications account for 74% to 85% of all complications arising from acute sinusitis, and anything involving vision, eye movement, or bulging of the eye needs same-day specialist review. Readers also search for perianal cellulitis and breast cellulitis, which are site-specific forms of the same underlying infection rather than separate diseases.
When cellulitis is an emergency
Most cellulitis is handled with antibiotic tablets at home. But a specific cluster of symptoms suggests the infection is moving through the body rather than staying local, and those warrant same-day emergency assessment rather than a wait-and-see approach.
Go to emergency care if any of the following appear alongside a skin infection:
- A very high temperature, or feeling hot, cold, or shivery
- A fast heartbeat or fast breathing
- Purple patches, or dark, blistered, or blackened skin
- Pain that is far more severe than the appearance of the skin suggests
- Dizziness or faintness
- Confusion or unusual drowsiness
- Cold, clammy, pale skin
These are the criteria that call for urgent review, and there is a good reason not to wait for a test to settle the question. In necrotizing soft tissue infection, a rare but rapidly destructive infection of the tissue under the skin, fever is present in only about 46% of cases, and no scoring system or scan reliably rules it out. Being seen in person, quickly, is what changes the outcome.
How cellulitis is diagnosed
Cellulitis is identified clinically, meaning a clinician reaches the conclusion from your history and a physical examination. No blood test or scan confirms it.
An assessment for a suspected skin infection usually runs through the same sequence, because in the absence of a gold-standard test the diagnosis rests on history, examination, and watching how things change:
- History of any skin break, recent injury, insect bite, or previous episodes
- Examination of the area for warmth, swelling, tenderness, and how well defined the border is
- Comparison with the same spot on the opposite limb
- Marking the edge of the redness with a pen so spread or retreat can be judged objectively
- Bloodwork or imaging, added only when the picture is unclear or you are systemically unwell
Getting this wrong is common enough to plan for. Among patients admitted for lower-extremity cellulitis, 30.5% turned out to have a different condition entirely, and most of them needed neither hospitalization nor antibiotics. That is the case for a second look rather than a longer prescription when redness is not behaving as expected: specialist dermatology review reclassified a third of presumed cases, with antibiotics safely stopped in most of those.
What tests and lab markers are used
Testing in cellulitis serves a different purpose than most people expect. Tests judge severity and rule out other causes rather than confirm the diagnosis.
In practice, that means a short list. Blood cultures are not routinely recommended in uncomplicated cellulitis because the yield is low and false positives are common, though they stay firmly indicated when someone is septic or severely unwell. A raised white cell count is one of the findings that makes true cellulitis more likely than a mimic, alongside one-sided involvement, a fast heart rate, and age 70 or over. Imaging does not settle it either, since a simple bedside clinical assessment outperformed thermal imaging at separating cellulitis from its look-alikes.
How cellulitis is treated
Cellulitis is managed with antibiotics, and the pivotal decision is severity: whether tablets at home are enough or intravenous antibiotics in hospital are needed.
Which antibiotic depends on whether there is pus. Most spreading cellulitis without pus is streptococcal and responds to penicillin-class (beta-lactam) antibiotics, with one prospective series reporting a 95.8% overall response rate to beta-lactams. Cellulitis with pus or an abscess is more likely staphylococcal and managed on a different footing, while routine MRSA coverage is not recommended for non-purulent cellulitis.
Course length is a range, not a fixed number. A 5-day course is recommended for uncomplicated cellulitis and extended if the infection has not improved, and a randomized trial found 5 days matched 10 days with success in 98% of both groups, but only among people already improving by day 5. Severe hospitalized cellulitis behaves differently: a 6-day course produced more relapses by day 90 than 12 days, so longer treatment is typical there.
| Severity | Typical presentation | Setting of care | Expected time to improvement |
|---|---|---|---|
| Mild | Local redness, warmth, and swelling with no systemic signs | Oral antibiotics at home, about 5 days | Improvement within 2 to 3 days |
| Moderate | Larger or faster-spreading area with systemic signs such as fever | Oral or intravenous antibiotics depending on response | Reassessment at 2 to 3 days if not improving |
| Severe | Systemic illness, failed oral therapy, or signs of deeper infection | Intravenous antibiotics in hospital, often around 12 days | Judged daily in hospital |
Mild cellulitis treated at home
Mild cellulitis without systemic signs is usually managed with oral antibiotics at home, with the affected limb elevated, and a few simple habits do most of the supporting work.
The standard self-care advice is short on both sides:
- Do raise the affected part above heart level where you can
- Do keep the nearby joint moving to limit stiffness
- Do drink fluids
- Do finish the full antibiotic course
- Don't stop antibiotics early because the skin looks better
- Don't bandage the area tightly
- Don't squeeze, pick at, or try to drain the area
Painkillers sit alongside all of this, not instead of it. Adding oral anti-inflammatory painkillers to antibiotics improved early response at day 3 in pooled trial data with no sustained benefit afterwards and no difference in overall resolution, which places them squarely in the symptom-relief column.
Severe cellulitis needing IV antibiotics
Cellulitis moves to hospital and intravenous antibiotics when the infection is severe or someone is systemically unwell, and current practice reviews also put failure of oral treatment among the reasons to escalate.
Two situations change the plan entirely rather than just the route of delivery. A collection of pus generally needs drainage as well as antibiotics, since antibiotics alone struggle to penetrate a walled-off abscess. And suspected necrotizing soft tissue infection is a surgical emergency, where immediate broad-spectrum antibiotics and surgical debridement ideally within 6 hours of presentation drive the outcome.
How long cellulitis takes to heal and what recovery looks like
Mild cellulitis is usually managed with about a week of antibiotic tablets, and most people recover fully within 7 to 10 days. Symptoms may intensify across the first 48 hours before turning the corner, so the trajectory matters more than any single day.
There is a clear checkpoint worth marking on the calendar. If there is no improvement 2 to 3 days after starting antibiotics, that is the moment to go back to a clinician rather than wait it out. Persistent non-response is also the point at which the diagnosis itself deserves questioning, because specialist review frequently identifies a non-infectious condition instead.
Skin takes longer to look normal than it takes to feel better. Discoloration, dryness, and flaking can linger for weeks after the infection has cleared, and uncomplicated cellulitis that responds to antibiotics generally resolves without lasting damage, with serious complications uncommon.
Complications of untreated cellulitis
Left untreated, cellulitis does not simply stay put. The infection can spread deeper into tissue and into the bloodstream, which is the step that turns a skin problem into a medical emergency.
The recognized complications are these:
- Abscess formation, a walled-off pocket of pus that usually needs draining
- Bacteremia and sepsis, meaning bacteria in the bloodstream and the body's overwhelming response to it
- Necrotizing soft tissue infection, in which tissue beneath the skin dies rapidly
- Lymphatic damage, which leaves persistent swelling and sets up further episodes
- Spread to nearby structures such as bone or a joint
- For infection around the eye, extension behind the eye socket into the orbit
Perspective belongs here too. In a population-based analysis, 82% of people had only one episode over five years and complications such as necrotizing fasciitis were very rare. The reason clinicians treat promptly anyway is that untreated necrotizing soft tissue infection is life- and limb-threatening and frequently recognized late, because its earliest symptoms look nonspecific.
Why cellulitis keeps coming back, and how to prevent it
Cellulitis has a memory. Recurrence reaches 6.3% within 12 months after a first episode, 17.2% after a second, and 29.4% after a third, climbing by 5 years to 13.9%, 35.9%, and 52.9%. Each episode makes the next one more likely, which reframes risk reduction as the main event rather than an afterthought.
The people most likely to see it return are those carrying the same background conditions that invited the first episode:
- Long-standing leg swelling or lymphedema
- An open wound or leg ulcer
- Untreated athlete's foot
- Venous insufficiency with chronic skin changes
- Higher body weight
- Any previous episode of cellulitis
Lowering that risk follows directly from that list, and the highest-yield work happens between episodes rather than during one. Guidelines put the emphasis on managing the predisposing conditions, particularly tinea pedis and edema:
- Clear athlete's foot properly and keep the skin between the toes dry
- Moisturize dry, cracked skin so it stops splitting
- Clean and cover breaks in the skin early
- Manage leg swelling with the compression or elevation approach your clinician advises
- Address venous and weight-related factors over the long term
For people caught in a cycle of frequent episodes, prophylactic antibiotics enter the conversation. Prophylaxis is considered after roughly 3 to 4 episodes a year, and low-dose prophylactic penicillin cut recurrence to 22% versus 37% on placebo during treatment in a randomized trial. Pooled evidence shows a 56% lower recurrence rate while prophylaxis is being taken, with the protection fading once it stops.
Track the markers behind recurrent cellulitis with a Superpower blood panel
Repeat episodes of cellulitis often sit on top of modifiable background factors: blood sugar control, body weight, and baseline inflammation. Bloodwork does not identify an active skin infection or lower the risk of one, but watching those underlying numbers over time is far easier with regular testing. Superpower's Baseline Panel includes HbA1c, high-sensitivity CRP, and white blood cell count alongside 100+ biomarkers, so you can see where your baseline sits and how it moves.
Frequently Asked Questions
References
- Brown BD, Syed HA & Hood Watson KL (2025). *Cellulitis*. StatPearls Publishing.
- Ellis Simonsen SM, van Orman ER, Hatch BE, et al. (2006). Cellulitis incidence in a defined population. *Epidemiology and Infection*, *134*(2), 293–299. https://doi.org/10.1017/S095026880500484X
- Garcia BM, Cruz-Diaz C, Agnihothri R, Shinkai K (2021). Distinguishing cellulitis from its noninfectious mimics: approach to the red leg. *Infectious Disease Clinics of North America*, *35*(1), 61–79. https://doi.org/10.1016/j.idc.2020.10.001
- Raff AB, Weng QY, Cohen JM, et al. (2017). A predictive model for diagnosis of lower extremity cellulitis: a cross-sectional study. *Journal of the American Academy of Dermatology*, *76*(4), 618–625.e2. https://doi.org/10.1016/j.jaad.2016.12.044
- National Health Service (2024). *Cellulitis*. NHS.
- Wong CM, Scheufele CJ, Bodapativ S, et al. (2022). Presentations of cutaneous disease in various skin pigmentations: cutaneous abscesses. *HCA Healthcare Journal of Medicine*, *3*(3), 153–159. https://doi.org/10.36518/2689-0216.1431
- Bruun T, Oppegaard O, Kittang BR, et al. (2016). Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study. *Open Forum Infectious Diseases*, *3*(1), ofv181. https://doi.org/10.1093/ofid/ofv181
- Shuman EK, Malani PN (2017). Empirical MRSA coverage for nonpurulent cellulitis: swinging the pendulum away from routine use. *JAMA*, *317*(20), 2070–2071. https://doi.org/10.1001/jama.2017.5654
- Quirke M, Ayoub F, McCabe A, et al. (2017). Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. *British Journal of Dermatology*, *177*(2), 382–394. https://doi.org/10.1111/bjd.15186
- Taira KG, Wang M, Guo W, et al. (2024). Association of cellulitis with obesity: systematic review and meta-analysis. *JMIR Dermatology*, *7*, e54302. https://doi.org/10.2196/54302
- Zacay G, Hershkowitz Sikron F, Heymann AD (2021). Glycemic control and risk of cellulitis. *Diabetes Care*, *44*(2), 367–372. https://doi.org/10.2337/dc19-1393
- McNamara DR, Tleyjeh IM, Berbari EF, et al. (2007). Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. *Mayo Clinic Proceedings*, *82*(7), 817–821. https://doi.org/10.4065/82.7.817
- Wong SJ, Levi J (2018). Management of pediatric orbital cellulitis: a systematic review. *International Journal of Pediatric Otorhinolaryngology*, *110*, 123–129. https://doi.org/10.1016/j.ijporl.2018.05.006
- Fernando SM, Tran A, Cheng W, et al. (2019). Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis. *Annals of Surgery*, *269*(1), 58–65. https://doi.org/10.1097/SLA.0000000000002774
- Boettler MA, Kaffenberger BH, Chung CG (2022). Cellulitis: a review of current practice guidelines and differentiation from pseudocellulitis. *American Journal of Clinical Dermatology*, *23*(2), 153–165. https://doi.org/10.1007/s40257-021-00659-8
- Edwards G, Freeman K, Llewelyn MJ, Hayward G (2020). What diagnostic strategies can help differentiate cellulitis from other causes of red legs in primary care? *BMJ*, *368*, m54. https://doi.org/10.1136/bmj.m54
- Weng QY, Raff AB, Cohen JM, et al. (2017). Costs and consequences associated with misdiagnosed lower extremity cellulitis. *JAMA Dermatology*, *153*(2), 141–146. https://doi.org/10.1001/jamadermatol.2016.3816
- Li DG, Xia FD, Khosravi H, et al. (2018). Outcomes of early dermatology consultation for inpatients diagnosed with cellulitis. *JAMA Dermatology*, *154*(5), 537–543. https://doi.org/10.1001/jamadermatol.2017.6197
- Long B, Koyfman A (2016). Best clinical practice: blood culture utility in the emergency department. *Journal of Emergency Medicine*, *51*(5), 529–539. https://doi.org/10.1016/j.jemermed.2016.07.003
- Li DG, Dewan AK, Xia FD, et al. (2018). The ALT-70 predictive model outperforms thermal imaging for the diagnosis of lower extremity cellulitis: a prospective evaluation. *Journal of the American Academy of Dermatology*, *79*(6), 1076–1080.e1. https://doi.org/10.1016/j.jaad.2018.06.062
- Stevens DL, Bisno AL, Chambers HF, et al. (2014). Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. *Clinical Infectious Diseases*, *59*(2), e10–e52. https://doi.org/10.1093/cid/ciu444
- Jeng A, Beheshti M, Li J, Nathan R (2010). The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. *Medicine (Baltimore)*, *89*(4), 217–226. https://doi.org/10.1097/MD.0b013e3181e8d635
- Hepburn MJ, Dooley DP, Skidmore PJ, et al. (2004). Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. *Archives of Internal Medicine*, *164*(15), 1669–1674. https://doi.org/10.1001/archinte.164.15.1669
- Cranendonk DR, Opmeer BC, van Agtmael MA, et al. (2020). Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial. *Clinical Microbiology and Infection*, *26*(5), 606–612. https://doi.org/10.1016/j.cmi.2019.09.019
- Hamill L, Keijzers G, Robertson S, et al. (2024). Anti-inflammatories as adjunct treatment for cellulitis: a systematic review and meta-analysis. *CJEM*, *26*(7), 472–481. https://doi.org/10.1007/s43678-024-00718-z
- McDermott J, Kao LS, Keeley JA, et al. (2024). Necrotizing soft tissue infections: a review. *JAMA Surgery*, *159*(11), 1308–1315. https://doi.org/10.1001/jamasurg.2024.3365
- Cannon J, Dyer J, Carapetis J, Manning L (2018). Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. *Clinical Microbiology and Infection*, *24*(10), 1084–1088. https://doi.org/10.1016/j.cmi.2018.01.023
- Thomas KS, Crook AM, Nunn AJ, et al. (2013). Penicillin to prevent recurrent leg cellulitis. *New England Journal of Medicine*, *368*(18), 1695–1703. https://doi.org/10.1056/NEJMoa1206300
- Dalal A, Eskin-Schwartz M, Mimouni D, et al. (2017). Interventions for the prevention of recurrent erysipelas and cellulitis. *Cochrane Database of Systematic Reviews*, *2017*(6), CD009758. https://doi.org/10.1002/14651858.CD009758.pub2
















